Inactive Instrument

News Kinder Holding Corp OTC Bulletin Board

Equities

US4945261067

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Nexien BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-20	CI
Nexien BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	11-14	CI
Nexien BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	28/09/23	CI
Nexien BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	17/05/23	CI
NEXIEN BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION (form 10-Q)	08/02/23	AQ
Nexien BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	08/02/23	CI
NEXIEN BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION (form 10-Q)	09/11/22	AQ
Nexien BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022	09/11/22	CI
NEXIEN BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	28/09/22	AQ
Nexien BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022	28/09/22	CI
Nexien BioPharma, Inc. Auditor Raises 'Going Concern' Doubt	27/09/22	CI
NEXIEN BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION (form 10-Q)	12/05/22	AQ
Nexien BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	12/05/22	CI
NEXIEN BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION (form 10-Q)	08/02/22	AQ
Nexien BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	08/02/22	CI
NEXIEN BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	21/01/22	AQ
Nexien BioPharma, Inc. announced that it has received $0.15 million in funding from Quick Capital, LLC	17/01/22	CI
NEXIEN BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION (form 10-Q)	22/11/21	AQ
Nexien BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021	22/11/21	CI
NEXIEN BIOPHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	12/10/21	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Kinder Holding Corp OTC Bulletin Board

Equities

US4945261067

Summary

Filters